Vyome Holdings, Inc. (HIND)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $11.09M
Last updated: Nov 17, 2026 at 11:02 AM ET
Vyome Holdings, Inc. (HIND) Stock Forecast
Analysts expect Vyome Holdings (HIND) to earn -$0.65 per share in the fiscal year ending Dec 31, 2026, on revenue of $103000. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 33.3% |
| Buy | 2 | 66.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 94.2%.
- Fiscal year ending Dec 31, 2026
- -$0.65
- EPS consensus, revenue $103000
- Fiscal year ending Dec 31, 2027
- -$0.80
- EPS consensus, revenue $200000
- Next report
- Mar 16, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.65 | -$0.86 to -$0.52 | 3 | $103000 | $90000 to $119000 | 3 |
| Dec 31, 2027 | -$0.80 | -$1.05 to -$0.57 | 3 | $200000 | N/A | 3 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.20 | -$0.23 to -$0.17 | 4 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.71.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.65 | -$0.55 | -$0.71 | -$0.71 | -$0.71 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.80 | -$0.80 | -$0.92 | -$0.92 | -$0.92 | N/A |
Frequently Asked Questions About HIND
What is the HIND stock forecast?
Consensus analyst estimates put Vyome Holdings's EPS at -$0.65 for the fiscal year ending Dec 31, 2026, on revenue of $103000. The consensus rating from 3 analysts is Buy.
How do analysts rate HIND stock?
Of 3 analysts covering Vyome Holdings, 1 rates it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from HIND next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.65, with estimates from -$0.86 to -$0.52 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.80, with estimates from -$1.05 to -$0.57 from 3 analysts.
What revenue do analysts expect from Vyome Holdings next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $103000, with estimates from $90000 to $119000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $200000.
How many analysts cover HIND?
3 analysts rate Vyome Holdings stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
HIND pages: Overview, Earnings, Forecast, Financials, Competitors